REQUEST A DEMO
Total
USD $0.00
Search more companies

Oculista Trade S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Oculista Trade S.R.O. Profile Updated: November 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Oculista Trade S.R.O. is an enterprise in Czech Republic, with the main office in Pelhrimov. It operates in the Pharmacies and Drug Stores industry. It was incorporated on March 08, 2017. It currently has a total number of 10 - 19 (2024) employees. From the latest financial highlights, Oculista Trade S.R.O. reported a net sales revenue drop of 1.87% in 2023. Its’ total assets recorded a negative growth of 28.96%. Oculista Trade S.R.O.’s net profit margin increased by 0.92% in 2023.

Headquarters
Karlovo namesti 201
Pelhrimov; Kraj Vysocina; Postal Code: 39301

Contact Details: Purchase the Oculista Trade S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Oculista Trade S.R.O. report to view the information.
Outstanding Shares:
Purchase the Oculista Trade S.R.O. report to view the information.
Registered Capital:
Purchase the Oculista Trade S.R.O. report to view the information.
Incorporation Date:
March 08, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Oculista Trade S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-1.87%
Total operating revenue
-1.87%
Operating profit (EBIT)
12.61%
EBITDA
-6.01%
Net Profit (Loss) for the Period
16.28%
Total assets
-28.96%
Total equity
15.14%
Operating Profit Margin (ROS)
1.07%
Net Profit Margin
0.92%
Return on Equity (ROE)
0.92%
Debt to Equity Ratio
-61.17%
Quick Ratio
-0.04%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?